Dr. Mar Hernández Guillamon Vall d’Hebron Research Institute-VHIR, Spain

Dr. Mar Hernández-Guillamon has dedicated her career to the study of cerebral amyloid angiopathy (CAA) and and other pathologies associated with the deposition of amyloid-beta (Aβ). In 2012, she was awarded by the Spanish Health Institute (ISCIII) to establish the Cerebral Amyloidosis line of research at the Neurovascular Lab (Vall... read mored’Hebron Research Institute, Barcelona, Spain). Her group has positioned in forefront of the Aβ-pathologies field, studying the molecular mechanisms involved in the Aβ transport and metabolism using in vitro and in vivo models, including different transgenic mouse models. Her lab has also dedicated to the clinical research and the discovery of biomarkers associated with CAA and other cerebrovascular diseases.